BioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. LYNX
10. SATL

Go back to BioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration
Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.47 -0.04 (1.59%)
Previous Close $2.51    52 Week High $1.63 
Open $2.52    52 Week Low $0.71 
Day High $2.52    P/E N/A 
Day Low $2.46    EPS $0.00 
Volume 14,321       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.47 -0.04 (1.59%)
Previous Close $2.51    52 Week High $1.63 
Open $2.52    52 Week Low $0.71 
Day High $2.52    P/E N/A 
Day Low $2.46    EPS $0.00 
Volume 14,321